Skip to main content
. 2020 Aug 27;2020(8):CD008213. doi: 10.1002/14651858.CD008213.pub3

Khalil 2016.

Study characteristics
Methods Study design: RCT, parallel‐group design with one study eye per child
Number randomized (total and per group): 28 eyes of 28 children; 14 in each group
Number analyzed (total and per group): 28 eyes of 28 children; 14 in each group
Losses to follow‐up: not reported
Length of follow‐up:
Planned: 3 years
Actual: 3 years
Sample size calculation (Y/N): Y (details of sample size and power not reported)
Participants Country: Egypt
Age: trabeculotomy: 6.52 ± 3.89 months; combined trabeculotomy–trabeculectomy with mitomycin C: 5.62 ± 3.96 months
Gender: trabeculotomy: 11/14 (78.6%) boys and 3/14 (21.4%) girls; combined trabeculotomy–trabeculectomy with mitomycin C: 11/14 (78.6%) boys and 3/14 (21.4%) girls
Inclusion criteria: primary congenital glaucoma in the first two years of life with no previous ocular surgeries
Exclusion criteria: any childhood glaucoma other than primary congenital glaucoma
Equivalence of baseline characteristics: "There was no significant difference between both groups regarding age and gender"
Interventions Intervention 1: trabeculotomy
Standard trabeculotomy
Intervention 2: combined trabeculotomy–trabeculectomy with mitomycin C
Trabeculotomy‐trabeculectomy with mitomycin C (0.2 mg/mL)‐soaked pieces of microsponge 494 mm2 were applied under the scleral flap and the conjunctiva for four minutes.
Outcomes Outcomes:
  • Mean IOP

  • Surgical success defined as resolution of corneal edema, reversal of disc cupping, and an IOP measurement of 18 mmHg or less on no IOP‐lowering medical treatment

  • C/D ratio

  • Adverse events


Intervals at which outcome assessed: month 1 and 6, year 1, 2, and 3.
Issues with outcome assessment: none
Adverse effects: yes
Notes Type of study: published
Funding: "This research received no specific grant from any funding agency in the public, commercial or not for‐profit sectors"
Declaration of interest: not reported
Study period: between January 2012 and September 2012
Clinical trial registry: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Infants with proved congenital glaucoma were randomly (using random computer‐generated numbers) allocated to either group A (trabeculotomy) or group B (combined trabeculotomy–trabeculectomy with mitomycin C) under general anaesthesia."
Allocation concealment (selection bias) Unclear risk Method of allocation concealment was not described.
Masking of participants and personnel (performance bias) Unclear risk Masking of participants and study personnel was not reported.
Masking of outcome assessment (detection bias) Unclear risk Masking of outcome assessors was not reported.
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Numbers of participants who were excluded or lost to follow‐up were not reported.
Selective reporting (reporting bias) Unclear risk Neither protocol nor clinical registry was available.
Other bias Unclear risk Conflicts of interest were not reported.